DR. HUYEN CAO, MD
Osteopathic Medicine at Parnassus Ave, San Francisco, CA
License number
California G72686
Category
Osteopathic Medicine
Type
Internal Medicine
License number
California G72686
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
400 Parnassus Ave, San Francisco, CA 94143
Phone
(415) 476-9936
(415) 476-7964 (Fax)
(415) 476-4029
(415) 476-4150 (Fax)
(415) 476-7964 (Fax)
(415) 476-4029
(415) 476-4150 (Fax)
Personal information
See more information about HUYEN CAO at radaris.comName
Address
Phone
4639 W Buena Vista Ct, Visalia, CA 93291
4509 Posada Ave, Bakersfield, CA 93309
3101 Heritage Valley Dr, San Jose, CA 95148
13742 Hale Cir, Garden Grove, CA 92844
288 Irish Way, Pismo Beach, CA 93449
Organization information
See more information about HUYEN CAO at bizstanding.comHuyen Cao MD
3490 California St, San Francisco, CA 94118
Industry:
Internist
Phone:
(415) 514-6200 (Phone)
Huyen Cao
Professional information
Dr. Huyen Cao, Richmond CA - MD (Doctor of Medicine)
Specialties:
Infectious Disease Medicine
Address:
CA Dpt Of Public Health
850 Marina Bay Pkwy, Richmond 94804
(510) 620-3737 (Phone)
850 Marina Bay Pkwy, Richmond 94804
(510) 620-3737 (Phone)
Certifications:
Infectious Disease, 1996, Internal Medicine, 1993
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
CA Dpt Of Public Health
850 Marina Bay Pkwy, Richmond 94804
UCSF Medical Center
505 Parnassus Ave, San Francisco 94143
UCSF Medical Center at Mount Zion
1600 Divisadero St, San Francisco 94115
850 Marina Bay Pkwy, Richmond 94804
UCSF Medical Center
505 Parnassus Ave, San Francisco 94143
UCSF Medical Center at Mount Zion
1600 Divisadero St, San Francisco 94115
Education:
Medical School
University of California At San Francisco
Graduated: 1990
Stanford University
Massachusetts General Hospital
University of California At San Francisco
Graduated: 1990
Stanford University
Massachusetts General Hospital
Huyen Cao, Richmond CA
Specialties:
Internist
Address:
850 Marina Bay Pkwy, Richmond, CA 94804
400 Parnassus Ave, San Francisco, CA 94143
400 Parnassus Ave, San Francisco, CA 94143
Education:
University of California San Francisco, School of Medicine - Doctor of Medicine
Massachusetts General Hospital - Fellowship - Infectious Disease (Internal Medicine)
Stanford Hospital & Clinics - Residency - Internal Medicine
Massachusetts General Hospital - Fellowship - Infectious Disease (Internal Medicine)
Stanford Hospital & Clinics - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Infectious Disease (Internal Medicine)
Huyen Le Cao, San Francisco CA
Specialties:
Internal Medicine, Infectious Disease
Work:
UCSF Medical Center / Moffitt-Long Hospitals
3490 California St, San Francisco, CA 94118
3490 California St, San Francisco, CA 94118
Education:
University of California at San Francisco (1990)
Director At Cadhs
Location:
San Francisco Bay Area
Industry:
Research
Methods Of Delivery Of Exogenous Proteins To The Cytosol And Uses Thereof
US Patent:
8333953, Dec 18, 2012
Filed:
May 18, 2010
Appl. No.:
12/782659
Inventors:
Yichen Lu - Wellesley MA, US
Huyen Cao - San Francisco CA, US
Huyen Cao - San Francisco CA, US
Assignee:
The General Hospital Corporation - Boston MA
President and Fellows of Harvard College - Boston MA
President and Fellows of Harvard College - Boston MA
International Classification:
A61K 49/00, A61K 39/00, A61K 39/04
US Classification:
424 91, 424 92, 4241851, 4241901, 4241921, 4242341, 4242481
Abstract:
The present invention is directed to a method for delivering exogenous proteins to the cytosol, by binding a target antigen (such as a protein) to a transport factor that contains a fragment of a bipartite protein exotoxin, but not the corresponding protective antigen. Preferably, the target antigen is fused to the transport factor. Preferred transport factors include the protective antigen binding domain of lethal factor (LFn) from , consisting of amino acids 1-255, preferably a fragment of at least 80 amino acids that shows at least 80% homology to LFn, and a fragment of about 105 amino acids from the carboxy portion that does not bind PA. The target antigen can include any molecule for which it would be desirable to elicit a CMI response, including viral antigens and tumor antigens.
Methods Of Delivery Of Exogenous Proteins To The Cytosol And Uses Thereof
US Patent:
2005022, Oct 6, 2005
Filed:
Mar 28, 2002
Appl. No.:
10/473190
Inventors:
Yichen Lu - Wellesley MA, US
Huyen Cao - San Francisco CA, US
Huyen Cao - San Francisco CA, US
International Classification:
G01N033/554, G01N033/569, C07H021/04, C12P021/04, A61K039/02, C07K014/195, C12N001/21, C12N015/74
US Classification:
424190100, 435007320, 435069700, 435252300, 435471000, 530350000, 536023700
Abstract:
The present invention is directed to a method for delivering exogenous proteins to the cytosol, by binding a target antigen (such as a protein) to a transport factor that contains a fragment of a bipartite protein exotoxin, but not the corresponding protective antigen. Preferably, the target antigen is fused to the transport factor. Preferred transport factors include the protective antigen binding domain of lethal factor (LFn) from , consisting of amino acids 1-255, preferably a fragment of at least 80 amino acids that shows at least 80% homology to LFn, and a fragment of about 105 amino acids from the carboxy portion that does not bind PA. The target antigen can include any molecule for which it would be desirable to elicit a CMI response, including viral antigens and tumor antigens.
Therapeutic Immunization In Hiv Infected Subjects To Augment Antiretroviral Treatment
US Patent:
2013011, May 9, 2013
Filed:
Jun 9, 2011
Appl. No.:
13/703174
Inventors:
Yichen Lu - Wellesley MA, US
Huyen Cao - San Francisco CA, US
Huyen Cao - San Francisco CA, US
Assignee:
VACCINE TECHNOLOGIES, INCORPORATED - Wellesley MA
International Classification:
A61K 39/12, A61K 39/08
US Classification:
4241901
Abstract:
The present invention generally relates to HIV compositions and methods of use. One aspect of the present invention relates to a composition comprising a pharmaceutically acceptable carrier and an antigen preparation, the antigen preparation comprising an HIV polypeptide or fragment thereof and a lethal factor (LF) polypeptide, such as a LFn polypeptide. In some embodiments, the LF polypeptide can be fused or otherwise associated with the HIV polypeptide. Other aspect of the present invention relate to use of vaccine comprising a HIV polypeptide and a lethal factor (LF) polypeptide in methods to enhance efficacy traditional antiretroviral therapy.